Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01448772 · ClinicalTrials.gov registry record · Phase 1
Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions
A Phase 1 study, sponsored by INSYS Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT01448772 is a Phase 1 study that has completed, run by INSYS Therapeutics. The registered enrollment target is 88 participants.
The verdict
NCT01448772, a Phase 1 study, has completed, sponsored by INSYS Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
This is a comparative study to assess bioavailability of a proposed alternate dosage form against the current FDA-approved branded product.
Interventions
- DRUG Dronabinol Capsules, 5 mg
- DRUG Dronabinol Oral Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2011-10 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01448772
The ClinicalTrials.gov registry entry for NCT01448772 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is INSYS Therapeutics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dronabinol Capsules, 5 mg is the first listed.
NCT01448772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01448772 about?
NCT01448772 is a clinical study titled "Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions". This is a comparative study to assess bioavailability of a proposed alternate dosage form against the current FDA-approved branded product.
What is the current status of trial NCT01448772?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2011-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01448772?
The interventions under investigation include: Dronabinol Capsules, 5 mg (DRUG), Dronabinol Oral Solution (DRUG).
Who is sponsoring clinical trial NCT01448772?
This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.